Breakingviews

MetLife CEO should revel in his anonymity

July 29, 2014

That almost no one knows ol’ so-and-so is good for shareholders. How he handles the mega-insurer’s likely designation as a systemic threat could change that. A Jamie Dimon-style fight would be foolish. Better to speak softly and keep the name Steve Kandarian out of headlines.

EU eases insurers’ worst capital fears – for now

March 22, 2012

The European Parliament has accepted that British insurers need protection from the EU’s sprawling new regulatory framework. That’s a relief. But the Solvency II rules could yet have unpleasant consequences. The likes of Pru could still move their headquarters away from Europe.

AIA’s new chief could unlock two deals

July 19, 2010

In giving its Asia chief executive the chop, American International Group may have unlocked two deals. First, the flotation of its AIA division in Hong Kong, which should now go ahead after a false start. Second, an eventual merger between AIA and the Asian portion of its big rival -- and recent failed suitor -- the UK's Prudential.

Axa will have to dig deeper for Asian buyout

November 9, 2009

For the second time in five years, minority shareholders in Axa Asia-Pacific Holdings face the prospect of being bought out on the cheap. The parent, Axa SA, has got into bed with AMP and the Aussie life assurer is bidding $10.3 billion for the whole of Axa Asia.

Axa will have to dig deeper for Asian buyout

November 9, 2009

For the second time in five years, minority shareholders in Axa Asia-Pacific Holdings  face the prospect of being bought out on the cheap. The parent, Axa SA, has got into bed with AMP and the Aussie life assurer is bidding $10.3 billion for the whole of Axa Asia.

The contradictions at ObamaCare’s heart

October 26, 2009

At the heart of the economic case for U.S. healthcare reform is a simple comparison: Whereas America spends 16 percent of GDP on healthcare, the average across OECD countries was 8.9 percent, as of 2007.

Private equity patient capital gets restless

October 13, 2009

Private equity relies on long-term, so-called "patient" capital of the sort supplied by pension funds and insurance companies. This is a model that has served the industry well over the past quarter century. By locking investors in, buyout firms were able to manage investments without worrying unduly about short term performance. But it breaks down when, as now, patient capital becomes restless. The situation at French buyout firm PAI Partners shows how fraught it can become when investors fall out with their buyout firms.